Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114627) titled 'A Cohort Study on Hearing Loss After Radiotherapy/Chemotherapy in Head and Neck Cancer Patients: Clinical Features and Treatment Outcomes' on Dec. 16, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Eye & ENT Hospital of Fudan University
Condition:
Hearing Loss After Radiotherapy/Chemotherapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-16
Target Sample Size: Patient group with Hearing Loss Following Radiotherapy/Chemotherapy:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300897
Di...